William Collier Email

President and CEO . Arbutus Biopharma

Current Roles

Employees:
101
Revenue:
$10.2M
About
Arbutus Biopharma Corporation is a publicly-traded (NASDAQ: ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We believe that Arbutus' comprehensive HBV pipeline of drugs and drug candidates optimally positions us to transform the HBV treatment landscape and to capitalize on the HBV global market opportunity. We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy to cure HBV.
Arbutus Biopharma Address
701 Veterans Circle
Warminster, PA
United States
Arbutus Biopharma Email

Past Companies

Arbutus Biopharma CorporationPresident and Chief Executive Officer
ViiV HealthcarePresident, North America
GSKSVP Office of the CEO

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.